Statistics
Publications
6
Citations
336
H-Index
6
Active since
2017
Hye Na Kim is an author at University of Southern California specializing in oncology, chemotherapy, and therapeutic resistance.
Publications per year
2017–2020
6
6
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
Kristen Fousek, Junji Watanabe, Sujith K. Joseph et al. · Leukemia · 2020 · 184 citations · Full text
Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia
Eun Ji Gang, Hye Na Kim, Yao‐Te Hsieh et al. · Blood · 2020 · 57 citations · Full text
Medicine, Cancer Biology, Oncology +14
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL
Etai Adam, Hye Na Kim, Eun Ji Gang et al. · Cancers · 2017 · 16 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 6